O áudio deste episódio pode não estar acessível.
How to fix it?
SOBRE ESTE EPISÓDIO
Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.03.29.534695v1?rss=1
Authors: Poulet, C., Debit, A., Josse, C., Jerusalem, G., Azencott, C.-A., Bours, V., Van Steen, K.
Abstract:
Biomarker signature discovery remains the main path to develop clinical diagnostic tools when the biological knowledge on a pathology is weak. Shortest signatures are often preferred to reduce the cost of the diagnostic. The ability to find the best and shortest signature relies on the robustness of the models that can be built on such set of molecules. The classification algorithm that will be used is selected based on the average performance of its models, often expressed via the average AUC. However, it is not garanteed that an algorithm with a large AUC distribution will keep a stable performance when facing data. Here, we propose two AUC-derived hyper-stability scores, the HRS and the HSS, as complementary metrics to the average AUC, that should bring confidence in the choice for the best classification algorithm. To emphasize the importance of these scores, we compared 15 different Random Forests implementation. Additionally, the modelization time of each implementation was computed to further help deciding the best strategy. Our findings show that the Random Forest implementation should be chosen according to the data at hand and the classification question being evaluated. No Random Forest implementation can be used universally for any classification and on any dataset. Each of them should be tested for both their average AUC performance and AUC-derived stability, prior to analysis.
Copy rights belong to original authors. Visit the link for more info
Podcast created by Paper Player, LLC
http://biorxiv.org/cgi/content/short/2023.03.29.534695v1?rss=1
Authors: Poulet, C., Debit, A., Josse, C., Jerusalem, G., Azencott, C.-A., Bours, V., Van Steen, K.
Abstract:
Biomarker signature discovery remains the main path to develop clinical diagnostic tools when the biological knowledge on a pathology is weak. Shortest signatures are often preferred to reduce the cost of the diagnostic. The ability to find the best and shortest signature relies on the robustness of the models that can be built on such set of molecules. The classification algorithm that will be used is selected based on the average performance of its models, often expressed via the average AUC. However, it is not garanteed that an algorithm with a large AUC distribution will keep a stable performance when facing data. Here, we propose two AUC-derived hyper-stability scores, the HRS and the HSS, as complementary metrics to the average AUC, that should bring confidence in the choice for the best classification algorithm. To emphasize the importance of these scores, we compared 15 different Random Forests implementation. Additionally, the modelization time of each implementation was computed to further help deciding the best strategy. Our findings show that the Random Forest implementation should be chosen according to the data at hand and the classification question being evaluated. No Random Forest implementation can be used universally for any classification and on any dataset. Each of them should be tested for both their average AUC performance and AUC-derived stability, prior to analysis.
Copy rights belong to original authors. Visit the link for more info
Podcast created by Paper Player, LLC
Inglês
Estados Unidos da América
PESQUISAR EPISÓDIOS PASSADOS
Pesquisar episódios anteriores de PaperPlayer biorxiv bioinformatics.
OUTROS EPISÓDIOS NESTE PODCAST
Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.08.01.551468v1?rss=1
Authors: Mukashyaka, P., Sheridan, T. B., Foroughi pour, A., Chuang, J. H.
Abstract:
Deep learning has revolutionized digital pathology, allowing for automatic analysis of hematoxylin and eosin (H&E) stain…
Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.07.31.551395v1?rss=1
Authors: Xu, Z.
Abstract:
Background: Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive lung disease characterized by excessive scarring of lung tissue. Recent studies have indicated a potential…
Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.08.04.410498v1?rss=1
Authors: Dick, K., Green, J. R.
Abstract:
No. While our experiments ultimately failed, this work was motivated by the seemingly reasonable hypothesis that encoding protein sequences as a fractal-based image in…
Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.08.01.551396v1?rss=1
Authors: Liu, S., Yu, J., Ni, N., Wang, Z., Chen, M., Li, Y., Xu, C., Bai, Q., Ding, Y., Wang, C., Zhang, J., Yao, X., Liu, H.
Abstract:
Predicting drug-target interaction (DTI) is a critical and rate-limiting…
Link to bioRxiv paper:
http://biorxiv.org/cgi/content/short/2023.08.04.551958v1?rss=1
Authors: Courtney, E., Datta, A., Mathews, D. H., Ward, M.
Abstract:
Determining RNA secondary structure is a core problem in computational biology. Fast algorithms for predicting secondary structure are funda…
Aviso: O podcast e a arte incorporada nesta página são de PaperPlayer, que é propriedade de seu proprietário e não é afiliado ou endossado por Listen Notes, Inc.
EDITAR
Obrigado por ajudar a manter a base de dados dos podcasts atualizada.